Diabetic Nephropathy Market is a rapidly growing sector in the healthcare industry, driven by the increasing prevalence of diabetes worldwide. Diabetic nephropathy, also known as diabetic kidney disease, is a serious complication of diabetes that affects the kidneys' ability to filter waste and excess fluids from the blood.
The market for diabetic nephropathy is primarily fueled by the rising number of individuals diagnosed with diabetes. According to the International Diabetes Federation, approximately 463 million adults were living with diabetes in 2019, and this number is projected to reach 700 million by 2045. As diabetes remains a major risk factor for developing kidney disease, the demand for effective treatments for diabetic nephropathy continues to surge.